Lexeo Therapeutics (LXEO) EPS (Basic) (2022 - 2023)
Historic EPS (Basic) for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $19.84.
- Lexeo Therapeutics' EPS (Basic) rose 32392.78% to $19.84 in Q4 2023 from the same period last year, while for Dec 2023 it was -$12.4, marking a year-over-year change of. This contributed to the annual value of -$3.09 for FY2024, which is 7508.06% up from last year.
- As of Q4 2023, Lexeo Therapeutics' EPS (Basic) stood at $19.84, which was up 32392.78% from -$12.36 recorded in Q3 2023.
- Lexeo Therapeutics' 5-year EPS (Basic) high stood at $19.84 for Q4 2023, and its period low was -$12.36 during Q3 2023.